PDS Biotech to Participate at B. Riley Securities 4th Annual Oncology Conference

January 17, 2024

https://www.globenewswire.com/news-release/2024/01/16/2809798/37149/en/PDS-Biotech-to-Participate-at-B-Riley-Securities-4th-Annual-Oncology-Conference.html

PRINCETON, N.J., Jan. 16, 2024 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq:PDSB) (“PDS Biotech” or “the Company”), a clinical-stage immunotherapy company developing a growing pipeline of targeted cancer immunotherapies and infectious disease vaccines based on the Company’s proprietary T cell activating platforms, today announced that Frank Bedu-Addo, PhD, President and Chief Executive Officer of PDS Biotech, will participate in a fireside chat at the B. Riley Securities 4th Annual Oncology Conference taking place virtually on Thursday, January 18, 2024, at 10:00 AM EST. Details are as follows:

Read more at globenewswire.com

Related news for (PDSB)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.